In this study, we investigated the possible roles of (1,3)-(1,6)-β-D-glucan (β-glucan) and porous electrospun poly-lactide-co-glycolide (PLGA) membranes containing β-glucan for skin wound healing, especially their effect on adult human dermal fibroblast (aHDF) and adipose tissue-derived stem cell (ADSC) activation, proliferation, migration, collagen gel contraction and biological safety tests of the prepared membrane. This study demonstrated that β-glucan and porous PLGA membranes containing β-glucan have enhanced the cellular responses, proliferation and migration, of aHDFs and ADSCs and the result of a collagen gel contraction assay also revealed that collagen gels contract strongly after 4 h post-gelation incubation with β-glucan. Furthermore, we confirmed that porous PLGA membranes containing β-glucan are biologically safe for wound healing study. These results indicate that the porous PLGA membranes containing β-glucan interacted favorably with the membrane and the topical administration of β-glucan was useful in promoting wound healing. Therefore, our study suggests that β-glucan and porous PLGA membranes containing β-glucan may be useful as a material for enhancing wound healing.
Introduction
β-glucans are a heterogeneous group of glucose polymers consisting of β- (1, 3) -linked β-D-glucopyranosyl units with a β- (1, 6) -linked side chain of varying distribution and length that mainly construct the outer cell walls of fungi and certain bacteria. They have been demonstrated to have immune stimulatory activity and to enhance wound healing especially by increasing macrophage infiltration into the injury sites and stimulating tissue granulation and re-epithelialization [1, 2] . Several preclinical and clinical investigations have indicated the usefulness of β-glucans, a class of biological response modifier (BRM), in the acceleration of wound healing and inhibition of systemic inflammatory response syndrome and septic shock [1] [2] [3] . These observations suggest that β-glucans and related immunomodulators may be useful adjuvant for healing, particularly in burn wounds.
Kougias et al have reported the presence of at least two glucan binding sites on normal human dermal fibroblasts other than on immunocytes like mammalian macrophages [4] . However, until now these kinds of investigation have not clarified the pathways of the effects of β-D-glucans on wound healing in vitro, and also in vivo. Up to now, a few clinical application cases have been reported, but there are no verified explanations about how β-glucan affects wound healing [5] .
There has been a recent surge of interest in the tissue engineering field to develop new materials/combinations for fabricating scaffolds with functional characteristics closely resembling those of the tissues they aim to restore [6, 7] . Much attention has been focused on designing implantable compliant biodegradable polymer scaffolds that target accelerating chronic wound repairs. Poly(D,L-lactic-co-glycolic acid) (PLGA) has been known as the most promising material and diverse applications in tissue engineering have been found for its excellent biocompatibility, biostability and biodegradability [8, 9] .
Electrospinning is a facile processing technique capable of converting polymers into inter-connected flexible nanofibrous structures, and it is particularly appealing for fabricating large sheets of scaffolds suitable for dermal implantation [10] .
In this study, we investigated the effects of β-glucan and the enhancement of cellular responses of adult human dermal fibroblasts (aHDFs) and adipose tissue-derived stem cells (ADSCs) on a porous electrospun PLGA membrane containing β-glucan as an alternative therapeutic strategy for damaged tissue.
Experimental details (1,3)-(1,6)-β-D-glucan, cells and cell culture
Water-soluble (1,3)-(1,6)-β-D-glucan from Aureoubasidium pullulans was obtained from Asahi Denka Co., Ltd (Tokyo, Japan) in a powder form (purity about 95%) as described in our previous study [11] . All reagents were purchased from Sigma-Aldrich Co. (St. Louis, MO) or GIBCO-BRL (Grand Island, NY) unless otherwise noted.
aHDFs were obtained from Cambrex BioScience Walkersville, Inc., and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 4.0 mM L-glutamine, 1.5 g L −1 sodium bicarbonate, 4.5 g L −1 glucose, 1.0 mM sodium pyruvate, 10% fetal bovine serum (FBS) and a 1% antibiotic antimycotic solution.
ADSCs were isolated from freshly excised human subcutaneous fat tissue.
Informed consent was obtained from each donor, and the study was approved by the Paik Hospital Institutional Review Board. The isolated ADSCs were maintained in DMEM/F12 containing 2.5 mM L-glutamine, 1.2 g L −1 sodium bicarbonate, 10% FBS, 10 ng mL −1 hEGF, 2 ng mL −1 hFGF and 1% antibiotic antimycotic solution.
Cell attachment, proliferation and migration by β-glucan
Cells, aHDFs and ADSCs, were plated in 24-well plates, treated with β-glucan and incubated for 4 h (with an initial cell density of 1.0 × 10 5 cells per well for an attachment assay), 1, 3 and 5 days (with an initial cell density of 5.0 × 10 4 cells per a film for a proliferation assay). After that, cells were incubated with 3-(4,5-dimethylthiazol-2-yl)-diphenyltetrazolium bromide (MTT) for 4 h and quantified by a colorimetric assay using a spectrophometer (Spectra Max 340, Molecular Device Co., Sunnyvale, CA) at a wavelength of 570 nm as previously described [12, 13] .
A cell migration study using a previously described method [12] attempted to evaluate the effect of β-glucan on the migration of aHDFs and ADSCs. Both cell types were plated at an initial density of 1.0 × 10 5 cells mL
in a 4-well chambered cover-glass slide and grown to confluence overnight in the culture medium. Monolayers were wounded using a plastic micropipette tip, treated with β-glucan (1.0 mg mL −1 ) and incubated in a self-designed CO 2 miniincubator placed on a microscope stage for 36 h. The wounded cells were visualized for migration of cells into the denuded space by a charge-coupled device (CCD) camera attached to the microscope (Olympus Optical Co. Ltd, Tokyo, Japan). The average speed of a single-cell migration was analyzed using the image-processing software MATLAB V7.0 (MathWork Inc., USA).
Fibroblast-embedded collagen gel assay
To study the influence of wound healing on β-glucan-induced collagen gel contraction, fibroblast-embedded collagen gel was prepared as previously described [14, 15] . Briefly, a collagen solution was prepared by mixing acid-soluble porcine type I collagen (3 mg mL −1 ), fivefold concentrated DMEM and buffer solution (0.05 mol L −1 NaOH, 2.2% NaHCO 3 , 200 mmol L −1 HEPES) at the ratio of 7:2:1:1, respectively. The collagen solution and aHDFs suspension were mixed (final concentration of type I collagen, 2.1 mg mL −1 ; final cell density, 1.0 × 10 5 cells mL −1 ) in ice bath. One milliliter of the mixture (cell suspension of aHDFs in serum-free DMEM and collagen solution, final concentration, 1.0 × 10 5 cells mL −1 and 2.1 mg mL −1 collagen) was plated in a 12-well culture plate (Costar Corp., Cambridge, MA) and incubated for gelation at 37
• C for 30 min. One milliliter of serum-free DMEM was then added on top of the gel to prevent the surface from dehydrating. The gel was separated and floated from each well and then treated with the various concentrations of β-glucan after incubation for 12 h. After gel floating, the major and minor axes of each gel sample were measured using an electronic caliper (Mitutoyo Corp., Kawasaki, Japan), and the NIH Image J software was used to quantify the areas of the collagen gels. The contraction of the gel was expressed in percentages, with the surface area of the non-contracted state serving as the norm (100%). Each value is equivalent to the mean of the triplicate measurements.
Preparation and characterization of the porous PLGA membrane and β-glucan grafting onto the scaffold PLGA (75:25 (mol mol −1 ), MW 71 000, Alkermes, Inc., Cambridge, MA) membranes were prepared by electrospinning, which is a facile processing technique capable of converting polymers into inter-connected flexible fibrous structures and is particularly appealing for fabricating large sheets of scaffolds suitable for dermal implantation [16] .
For the electrospun membranes, a series of PLGA solutions was prepared by dissolving the copolymers in tetrahydrofuran:N,N dimethylformamide (8:2) at a concentration of 20% (w/v), depending on the composition of the copolymer. The polymer solution was delivered at a constant flow rate (10 mL h −1 ) using an infusion pump to the stainless steel blunt-ended needle with an air gap between the metal collector and the needle tip of 20 cm at a driving voltage of 18 kV. β-glucan was grafted onto the surface of the PLGA membrane as previously described [13] . In brief, the β-glucan was dissolved in the phosphate buffer saline (PBS) solution to form a 5 mg mL −1 solution. The PLGA membrane was pre-wetted with 70% ethanol for 5 min to be sterilized, and then immersed in the β-glucan solution at 30
• C for 1 h. The membrane was then dried.
Biological safety test of the porous PLGA membrane containing β-glucan
Cellular toxicity test by the extract dilution method. As described by the document of International Standard ISO 10993-5 [17] , the MTT assay method was performed for cytotoxicity and the extracts of the PLGA membranes containing β-glucan were prepared by shaking at 100 rpm for 72 h at 37
• C and serially diluted by adding fresh DMEM (100%, 50%, 25%, 12.5%). For this study, the L-929 cells, mouse fibroblast cells (ATCC CCL 1, NCTC Clone 929, of strain L), were used. The cells were seeded into each well of the 24-well plate in triplicate and incubated at 37
• C for 24 h in order to obtain confluent monolayer's of cells prior to use. All cultures were incubated for 24 h, under the same growth conditions. After incubation, each culture was stained with a MTT solution and lysed with a DMSO solution. Absorbance was measured at 570 nm with an automatic microplate reader. The relative cell viability was expressed as a percentage of the optical densities of the samples with the medium containing diluted extracts to the optical densities of the samples grown in the fresh control medium.
MTT assays were used to estimate the cell attachment and proliferation on PLGA membranes as described above.
The morphologies of cells grown on the PLGA membrane containing β-glucan were observed after 5 days by a SEM (Hitachi S-800) at an accelerating voltage of 20 kV.
Intracutaneous (intradermal) reactivity test and sensitization test.
Two biological tests in vivo were performed according to the document of International Standard ISO 10993-10 [18] and the method described by Magnusson et al [19] .
For the intercutaneous reactivity test, a minimum of three healthy adult albino rabbits (New Zealand White variety) of either sex were obtained from an approved supplier, traceable in Yonsei Medical Technology & Quality Evaluation Center records. The animals were acclimated to the laboratory for at least 3 days. All animals weighed in excess of the 2.0 kg minimum ISO weight limit. The test article was extracted in 0.9% sodium chloride and cotton oil with a ratio of 6 cm 3 mL at 70
• C for 24 h. Each rabbit received three sequential 0.2 mL intracutaneous injections on either side of the dorsal mid-line: test article extracts on the one side and concurrent vehicle controls on the other. Observations for erythema and edema were carried out at 24, 48 and 72 h after the injections. The primary dermal irritation index (PDII) was scored on a 0-4 basis. Any adverse reactions at the test sites were also noted.
For the sensitization test, the method described by Magnusson was used to evaluate the allergic contact sensitization potential [19] . A guinea pig maximization test was performed to evaluate the potential for delayed dermal contact sensitization of the test article. A minimum of 20 healthy adult albino guinea pigs of either sex were obtained from an approved supplier, traceable in Yonsei Medical Technology & Quality Evaluation Center records. The animals were acclimated to the laboratory for at least 5 days. The range of animal weights at first treatment was 300-500 g. A known sensitizing agent, 1-chloro-2,4-dinitrobenzene (DNCB), was used as the positive control. Ten test guinea pigs (per extract) were injected with the test article and Freund's complete adjuvant (FCA), and five guinea pigs were injected with the corresponding control blank and FCA (intradermal induction phase). On day 6, the areas on the injection sites were treated with 10% sodium dodecyl sulfate (SDS). The day following the SDS treatment, the test animals were topically patched with the appropriate test extract and the control animals were patched with the corresponding control blank (topical induction phase). The patches were removed after 48 h of exposure. Following a 2 week rest period, the test animals were topically patched on a previously untreated area with the appropriate test extract, while the same was done for the control animals using a control blank (challenge phase). The patches were removed after 24 h of exposure. The dermal patch sites were observed for erythema and edema 24 and 48 h after patch removal. Each animal was assessed for a sensitization response based upon dermal scores.
Statistical analysis
All variables were tested in duplicate for each experiment, which was repeated twice. Quantitative data were expressed as a mean ± SD. Statistical comparisons were carried out with a Student's t-test. A value of p < 0.05 was considered statistically significant. Figure 1 shows the effect of β-glucan on cellular responses such as attachment and proliferation. The β-glucan dosedependently enhanced the proliferation of aHDFs for 5 days and the proliferation rate was significantly (p < 0.05) higher in comparison with control ( figure 1(B) ). However, there was no significant difference in attachment of aHDFs for 4 h ( figure 1(A) ). In ADSCs, β-glucan had no significantly different effect on both the attachment and proliferation rate as shown in figures 1(C) and (D). Cell movement is a combined effect of cell division and cell migration [20] . To examine the biological effects of β-glucan on the migration of aHDFs and ADSCs, wound healing migration assays were performed as shown in figure 2 . The migration speed of cells in the β-glucan treated group was faster than in the non-treated group. Furthermore, the average migration speed of the β-glucan-treated (1 mg mL −1 ) aHDF was 67.1 μm h −1 , while that of the non-treated group was 45.5 μm h −1 (figures 2(A) and (B)). In ADSCs, the cell migration assay showed that β-glucan was able to induce the migration of cells, although it had no proliferative effect on ADSCs as described above. The average migration speed of β-glucan-treated (1 mg mL −1 ) ADSCs was 86.3 μm h −1 , while that of the non-treated group was 72.1 μm h −1 as shown in figures 2(C) and (D).
Results

Effects of β-glucan on cells attachment, proliferation and cell migration
Collagen gel contraction assay
Three-dimensional collagen gels have been used as in vitro systems for modeling of cellular activities during wound healing [21] . This model system was adapted to assess the capability of β-glucan to induce collagen gel contraction in concert with cellular activities. These results are shown in figure 3 . The collagen gels contracted strongly during 4 h incubation after the post-gelation treatment with β-glucan, whereas there was no obvious change in gel size in the control ( figure 3(A) ). The contracted collagen gel diameters are summarized in figure 3(B) . After incubation for 24 h, the presence of the cell treated with β-glucan (1 and 2 mg mL −1 ) rendered collagen gel contraction to approximately 41.1 (p < 0.05) and 41.6% (p < 0.05) of its original size, respectively. In contrast, collagen gel without β-glucan contracted to 72%.
Proliferation of cells on the β-glucan contained PLGA membrane
To further analyze the ability of a scaffold to influence the growth of cells, aHDFs and ADSCs were cultured on β-glucan-containing PLGA membranes for 2 weeks and the cell viability was assayed with the MTT method at various points along this time course (figure 4). The cell density on the β-glucan-containing PLGA membrane was higher than that on the PLGA membrane without β-glucan in both cells. The cells in the membrane continued to proliferate up to the day 10. It is known as strong cell adhesion and spreading on biomaterials [22] . Figure 5 shows the SEM images of cell-free PLGA ( figure 5(A) ) and β-glucan-containing PLGA ( figure 5(B) ) and aHDFs on the PLGA ( figure 5(C) ) and β-glucan-containing PLGA ( figure 5(D) ) membrane. The morphologies of aHDF cultured on the PLGA membrane were spread morphology, whereas the cells on the β-glucan-containing PLGA membrane exhibited more spread in the polygonal shape which is typical of the normal cell morphology. The insets in figures 5(C) and (D) were magnified sections of the upper figures to observe the cells into the PLGA membrane. These characteristics are prerequisites for an effective reepithelialization of artificial skin materials.
Biological safety test of the β-glucan-containing PLGA membrane
Using the extract dilution method, the cytotoxicity of the β-glucan-containing PLGA membrane was performed and the test sample extract showed 91.3% of cell viability in comparison with the negative control as shown in figures 6(A) and (B). In the intracutaneous (intradermal) reactivity test, extracts of the β-glucan-containing PLGA membrane and negative control solutions did not trigger irritation responses at any circumstances as shown in table 1. No intracutaneous irritation was induced by the β-glucan-containing PLGA membrane, and no toxic symptoms or abnormal behaviors such as convulsion, prostration or sign of biological reactivity were observed at any injected sites with extracts or blank controls. Animals from all groups gained normal body weight 
Discussion
In order to evaluate the effects of β-glucan on wound healing, the cell proliferation and migration assays were carried out with aHDFs and ADSCs, and the β-glucan-containing PLGA membrane was evaluated by biological assays such as cell attachment, proliferation assays and biological safety tests. In our studies, the cell proliferation was significantly (p < 0.05) enhanced by the β-glucan after 5 days and the β-glucan-treated group in a migration assay was faster than nontreated control. These results indicate that cells with impaired proliferative capacity were able to migrate by the β-D-glucan. This could be beneficial for healing of chronic dermal wounds by proliferation, as cell migration and proliferation are two major contributory factors enhancing the healing of chronic wounds [23] .
The contraction of collagen gels by fibroblasts was first reported by Bell et al and is a phenomenon useful in the study of cell to collagen interactions (collagen morphogenesis) [24, 25] .
In this present study, we performed several experiments to study fibroblast-mediated collagen gel contraction.
These data suggest that β-glucan is constitutionally well suited for application in dermal wound healing. Dermal fibroblasts play key roles in skin extracellular protein turnover, extracellular matrix interaction, cell-cell communication, etc, which are closely related functions [26] . Prompting the wound healing process and identifying factors affecting wound healing after β-glucan exposure are complicated; therefore, it is challenging to develop new therapeutic strategies to improve the cure rate. In the later part of the second stage of wound repair, new tissue formation, fibroblast migration and proliferation is an important event. This event is orchestrated by various growth factors produced by fibroblasts and other cutaneous cell types, including platelets, inflammatory cells, keratinocytes and epithelial cells [27] .
The cell density on the β-glucan-containing PLGA membrane was higher than that on the PLGA membrane without β-glucan and biological safety was confirmed. The cell morphology and proliferation assay on the β-glucan-containing PLGA membranes showed that dermal fibroblasts well attached and moved in β-glucan-containing PLGA membranes without any cell adhesion facilitating component. It was distinctively different from the results of other studies describing various membranes in which cells failed to distribute uniformly in the matrices in conjunction with the majority of them attached only to the outer surfaces [28] . These results indicated that the β-glucancontaining PLGA membrane was non-toxic to cells and it has good biocompatibility. Furthermore, the homogeneous cell distribution inside the porous β-glucan-containing PLGA membrane resembles the normal dermal tissue, which is a desirable feature of dermal tissue engineered scaffolds as previously described [29] .
In conclusion, our study suggests that the β-glucan and β-glucan-containing porous PLGA membranes may be useful as a material for enhancing the wound healing, because they can promote cell proliferation, migration and collagen gel contraction.
